A cancer neuroscience-related gene model for prognosis prediction and immunotherapy response evaluation in breast cancer

Key Points

• The aim is to develop and validate a gene model to predict prognosis and immunotherapy responses in breast cancer.
• Developing a 12-gene prognostic model based on cancer neuroscience
• Validating the model using patient data
• Evaluating immune landscapes and responses to immunotherapy
• The model effectively stratifies patient risk for breast cancer
• Distinct immune landscapes are revealed
• Differential responses to immunotherapy and therapeutic agents are predicted